AGAbdi Leta Gemechu

Abdi Leta Gemechu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abdi Leta Gemechu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Ariaya Hymete

    Affiliation Addis Ababa University, College of Health Sciences, Department of Pharmaceutical Chemistry and Pharmacognosy, Addis Ababa, Ethiopia

    1 shared publication
  • Gamachu Diba

    College of Medicine and Health Science, Department of Pharmacy, Ambo University, Ambo, Ethiopia

    1 shared publication
  • Getahun Damissie

    College of Medicine and Health Science, Department of Pharmacy, Salale University, Fiche, Ethiopia

    1 shared publication
  • Mirutse Giday

    Affiliation Addis Ababa University, Aklilu Lemma Institute of pathobiology, Addis Ababa, Ethiopia

    1 shared publication
  • Misgana Aragaw Mekuria

    College of Medicine and Health Science, Department of Pharmacy, Wolkite University, Wolkite, Ethiopia

    1 shared publication
  • Solomon Tadesse

    Department of Biomedical and Pharmaceutical Sciences, L. S. Skaggs College of Pharmacy, Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID, 83209, USA

    1 shared publication

Latest Publications

  • Open Access

    Therapeutic potential of the genus Zehneria (Cucurbitaceae): a systematic review of ethnomedicinal uses, phytochemistry, and pharmacological activities, with a predominant focus on Zehneria scabra

    by Abdi Leta Gemechu, Gamachu Diba, Misgana Aragaw Mekuria, Getahun Damissie

    Background: The genus Zehneria (Cucurbitaceae) comprises medicinal plants widely used in traditional healthcare systems across Africa and Asia. Species such as Zehneria scabra are traditionally employed to treat infectious diseases, gastrointestinal disorders, inflammatory conditions, and skin ailments. Although numerous studies have investigated the ethnomedicinal uses, phytochemical constituents, and pharmacological activities of Zehneria species, the available evidence remains fragmented and is heavily weighted toward a single species, Zehneria scabra . Therefore, this systematic review aimed to synthesize existing evidence on the ethnomedicinal uses, phytochemistry, and pharmacological activities of the genus Zehneria , while explicitly noting where the evidence base is limited to this single species. Methods: A systematic literature search was conducted in PubMed, Google Scholar, Scopus, and ScienceDirect databases without time restrictions. The search strategy used keywords related to Zehneria , ethnomedicinal uses, phytochemistry, and pharmacological activity. The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Studies were screened using predefined inclusion and exclusion criteria, and only original research articles reporting ethnomedicinal, phytochemical, or pharmacological data were included. Data were extracted and synthesized using a qualitative descriptive approach. Results: A total of 1,188 records were identified, of which 1,173 remained after removing 15 duplicates; following title, abstract, and full-text screening, 40 studies met the inclusion criteria and were included in the final analysis. The findings indicated that Zehneria scabra is the most extensively studied species and is widely used in traditional medicine for managing infectious and inflammatory conditions, gastrointestinal disorders, and skin diseases. Pharmacological studies demonstrated multiple biological activities, including antimicrobial, antiplasmodial, anti-inflammatory, antioxidant, wound-healing, antidiarrheal, and insecticidal effects. Phytochemical investigations revealed diverse bioactive compounds, such as flavonoids, alkaloids, phenolic compounds, terpenoids, and triterpenoids, including novel compounds with potential therapeutic relevance. Conclusions: The genus Zehneria represents a pharmacologically promising group of medicinal plants with substantial ethnomedicinal relevance supported by preclinical experimental evidence. However, further research is required to standardize extraction methods, evaluate safety and toxicity, and conduct clinical studies to support the development of evidence-based therapeutic applications. Registration: PROSPERO [CRD420261446650]. Graphical Overview of the evidence synthesis pathway from ethnomedicinal knowledge to phytochemical and pharmacological validation of the genus Zehneria.

  • Open Access

    Evaluation of analgesic and anti-inflammatory activities of the root extract of Grewia schweinfurthii Burret and its major chemical constituents

    by Abdi Leta Gemechu, Mirutse Giday, Solomon Tadesse, Ariaya Hymete

    Despite the widespread use of conventional analgesic and anti-inflammatory drugs, their clinical utility is often limited by adverse effects, necessitating the search for safer alternatives from medicinal plants. This study investigated the analgesic and anti-inflammatory activities of the 80% methanolic root extract of Grewia schweinfurthii Burret and an isolated bioactive compound using established rodent models. Air-dried roots were extracted by maceration with 80% methanol, and acute oral toxicity was evaluated following OECD guidelines. Analgesic activity was assessed using the acetic acid–induced writhing and hot plate models in mice, while anti-inflammatory activity was evaluated using carrageenan-induced paw edema in rats. A bioactive compound, 4 (2ʺ-(4′-isopropylphenyl) propan-2ʺ-yl)-2,3-dihydrofuran, was isolated via column chromatography and tested for anti-inflammatory activity. In the writhing test, the extract produced significant (p < 0.001) dose-dependent inhibition of abdominal constrictions, with 13.90%, 56.81%, and 75.48% inhibition at 100, 200, and 400 mg/kg, respectively, compared to 80.77% inhibition by aspirin (150 mg/kg). In the hot plate model, the 400 mg/kg dose significantly prolonged latency time from a baseline of 5.67 ± 0.33 s to 9.17 ± 1.01 s at 120 min (p < 0.05), indicating central analgesic activity. In the carrageenan-induced paw edema model, the extract demonstrated marked anti-inflammatory effects, with 93% inhibition at 400 mg/kg at the 5th hour, comparable to indomethacin (95% inhibition). The isolated compound exhibited significant dose-dependent anti-inflammatory activity, achieving 75% inhibition at 40 mg/kg at 5 hours (p < 0.001). Overall, the findings demonstrate that G. schweinfurthii root extract and its isolated compound possess significant peripheral and central analgesic as well as potent anti-inflammatory activities, supporting the plant’s traditional use; however, further mechanistic, toxicological, and pharmacokinetic studies are required before clinical relevance can be established.